Unity Biotechnology, Inc. (UBX) Misses Q1 EPS by 59c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- Wall St turns lower as crude spikes, chip stocks weigh
- Oil jumps 5%, then pares gains after Trump says no attack on Iran this month
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts UBX Hot Sheet
Join SI Premium – FREE
Unity Biotechnology, Inc. (NASDAQ: UBX) reported Q1 EPS of ($0.76), $0.59 worse than the analyst estimate of ($0.17).
For earnings history and earnings-related data on Unity Biotechnology, Inc. (UBX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Potential Starbucks-Chipotle merger: major opportunity or expensive distraction?
- Aegon shareholders approve US redomiciliation at EGM
- Byrna Technologies Inc. (BYRN) Misses Q3 EPS by 9c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
